InVitae (NVTA) Misses Q2 EPS by 20c

InVitae (NYSE: NVTA) reported Q2 EPS of ($0.85), $0.20 worse than the analyst estimate of ($0.65). Revenue for the quarter came in at $116.3 million versus the consensus estimate of $108.3 million.

GUIDANCE:

InVitae sees FY2021 revenue of $475-500 million, versus the consensus of $463 million.

For earnings history and earnings-related data on InVitae (NVTA) click here.

You May Also Be Interested In

• North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
• Alto Neuroscience, Inc. (ANRO) Tops Q2 EPS by 10c
• SeaStar Medical (ICU) Misses Q1 EPS by 4c